1419385-74-2

Upstream product

• 40731-98-4 4-hydroxy-2,3-dihydroindan-1-one 
• 1419391-62-0 C₄₅H₅₄N₆O₄ 
• 1419391-59-5 C₄₅H₅₄N₂O₁₀ 
• 111398-44-8 N-methoxycarbonyl-L-valine 
• 1419387-69-1 C₂₃H₂₂Br₂O₂ 
• 1419387-66-8 C₂₃H₂₄O₂ 
• 171364-81-1 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone 
• 99-90-1 para-bromoacetophenone 
• 1419387-63-5 C₁₆H₁₇F₃O₄S 
• 1419387-60-2 C₁₅H₁₈O₂ 
• 1419387-57-7 C₁₆H₂₀O₂ 
• 1419386-97-2 C₁₄H₁₈O 
• 1419386-48-3 C₁₄H₁₆O₂ 
• 13336-31-7 4-methoxylindanone 

Relevant academic research and scientific papers

SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS

Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.